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Herbal Therapy
Introduction I am a clinical herbalist with more than 35 years of training and experience in Cherokee, Chinese, and Western/Eclectic herbal traditions. I have been in clinical practice for more than 28 years, and my focus for treatment is the person and their constitutional weaknesses as well as the specific disease. This means looking at diet, lifestyle, stress, medical and family history, as well as the current condition and the traditional Chinese Medicine energetics. I work with physicians, so my treatments are geared to working with conventional therapies. Herbs and diet can be direct therapies in some protocols, while in others, they can work to enhance the effectiveness of chemotherapy, reduce adverse effects associated with its use, 1 reduce cachexia, and support normal metabolic functioning.
In this case, the patient, a 51-year-old man, had a malignant melanoma surgically removed in September 2004. At present, he has no detectable cancer and would like to prevent recurrence of this aggressive cancer and metastasis and avoid treatment with interferon. From an herbal perspective, I would treat the patient rather than just treat the melanoma. This means supporting the immune, nervous, and endocrine systems with diet, herbs, supplements, and lifestyle changes. Foods and herbs with recognized antioxidant, anti-inflammatory, and antitumor activity will be emphasized. My general protocols for people with cancer involve rotating 2 sets of formulas. The first are alterative formulas used since the early 1800s by the Eclectic physicians to treat cancer and other "blood dyscrasias" and enhance elimination of wastes. 2 The second set of formulas are known as Fu Zheng formulas; they are used in Chinese medicine to enhance immune function and reduce the side effects associated with radiation or chemotherapy. 3
Recommendations

Diet
Melanoma is not directly associated with nutritional deficiencies, although some researchers suggest that abnormal ratios of omega-3 to omega-6 fatty acids may promote this deadly cancer. 4 As a general preventative, the diet should include foods rich in antioxidant, antiinflammatory, and tumor-inhibiting phytonutrients.
Mixed carotenoids and vitamin A are associated with reduced cancer levels. 5 Foods that are high in such nutrients are winter squash; pumpkin; apricots (dried); carrots; beets; yellow, red, or orange peppers; sweet potatoes; tomatoes; dark green leafy vegetables; cayenne pepper; paprika; and curry powder, In a recent animal study, increased β-carotene inhibited lung metastasis by melanoma cells. 6 Flavonoids (especially oligomeric procyanidins) are associated with anti-inflammatory, antioxidant, and antitumor activity. 5 Foods rich in flavonoids include blueberries, dark cherries, raspberries, purple or red grapes, blue corn, grape juice, pomegranate juice, elderberries, green tea, rosemary, thyme, and basil.
Omega-3 fatty acids inhibit carcinogenesis and metastasis in both in vitro and animal studies. 5 Alaskan wild salmon and sardines are sources of docosahexaenoic acid, which inhibits melanoma cells in cell culture studies. 7 Flaxseed has been shown to inhibit melanoma in animal studies 8 ; this may be due to its lignan content. If so, eating flaxseeds, rather than the oil, would have a greater therapeutic effect.
Isoflavones-including genistein, daidzein, and biochanin A-are found in soy beans and soy products, chickpeas, dried beans, lima beans, carob, and other members of the Fabaceae family. They inhibit metastasis of cancer cells and induce apoptosis. In both in vitro and in vivo studies, genistein was found to inhibit melanoma cells and promote differentiation. 9 Alliums-garlic, onions, shallots, leeks, scallions, ramps-all contain allyl sulfides that protect against carcinogenesis in a variety of cancers. 10, 11 A specific compound found in garlic, ajoene, has been shown in in vitro studies to have apoptotic and antiadhesion effects on murine melanoma cells. 12 Brassicas-broccoli, broccoli sprouts, brussels sprouts, cabbage, bok choy, turnip greens and roots, radishes, mustard greens, kohlrabi, broccoli rabe, cauliflower, kale, watercress, collards-all contain indoles, isothiocyanates, and sulforaphane, which inhibit tumor formation in cell cultures. 10(pp54-55) Several in vitro studies indicate that isothiocyanates and sulforaphane inhibit melanoma cell growth. 13 Other Foods With Beneficial Properties Celery stalk contains phthalides and polyacetanes, both of which inhibit cancer, especially caused by cigarette smoke. 10(p56) Because of this patient's history of smoking and exposure to secondhand smoke, I feel this would be a useful preventative choice.
Mushrooms-shiitake (Lentinula edodes), maitake (Grifola frondosa), and the caterpillar fungus (Cordyceps sinensis)-all have immune-enhancing activity. Cordyceps has been shown in animal studies to inhibit malignant melanoma by promoting natural killer (NK) cell activity and inhibiting tumor formation. 14 I would advise avoiding diet sodas, transfatty acids, fried foods, and excess omega-6 fatty acids to promote optimal health. In one study, 100 melanoma patients were found to have significantly higher levels of polyunsaturated fats in their adipose tissue than were controls. 15(pp415-416) Alcohol, except for small amounts in the tincture formula, should be avoided as consumption of more than 10 g per day of alcohol is associated with increased risk of melanoma. 15(p415) Herbal Therapy: Goals 
Supplements
Use a food-based multiple vitamin/mineral supplement to enhance overall health and to ensure there are no dietary deficiencies. Spirulina (tablets or powder) is a useful source of carotenoids, trace minerals, and omega-3 fatty acids. It has antimutagenic and antioxidant activity, and in an in vitro study, calcium spirulin, a sulfated polysaccharide derived from Spirulina, inhibited experimental lung metastasis from B16-BL6 melanoma by preventing adhesion and migration of tumor cells to the laminin substrate. 27
Lifestyle Changes
Avoid sun exposure and secondhand smoke. Get adequate sleep to maintain healthy melatonin and cortisol levels. 28 Constant stress depresses the immune system and elevates cortisol levels, which can stimulate the growth of some types of cancer cells. 28 In addition to the nervines and adaptogens in the herbal formula, stress reduction techniques such as meditation, prayer, Qi Gong, Tai Qi, or biofeedback would be beneficial. If the patient decides to use the interferon therapy, none of the recommended herbs are known to interfere with interferon or strongly affect the CYP450 system. 
Integrative Physician's Perspective, With a Special Consideration of St John's Wort
Malignant melanoma is a cancer for which some significant therapeutic advances have occurred in the past decade, but, as Dr Deva Nathan's contribution makes clear, these advances have certainly not solved the problems posed by this dangerous disease. Adjuvant therapy with high-dose interferon-α2b (IFN) has been subjected to several clinical trials, and while improvements have been shown in relapse-free survival time, overall survival does not appear to be improved by this therapy. Furthermore, IFN is plagued with numerous unpleasant side effects. This year's American Society of Clinical Oncology meeting did little to change this situation for stage II patients considering adjuvant therapy. One trial did report better overall survival for stage III patients with a regimen that comprised dacarbazine followed by low-dose interferon therapy. 1 The existence of such an adverse side effect profile with interferon therapy, together with the questionable benefits, make it clear that more is required in the management of melanoma patients. Our other contributors explore what integrative therapies may have to offer in this area.
Dr Michael Uzick has offered an exceptionally thorough review of the literature on natural agents that may be relevant to naturopathic management of melanoma. As he points out, many of the references involve in vitro and in vivo studies, and while it cannot be said that such studies are necessarily directly relevant to treatment or prevention in the patient context, the risk of using agents based on preclinical studies is moderated if they are widely acknowledged to be safe based on other studies. Given that survival rates after a melanoma diagnosis are definitely less than we would like, there is an argument to be made for use of agents that have few drawbacks in terms of toxicity but a potential upside in improving the overall health of a patient and the ability of the body to battle melanoma. Curiously, the use of high-dose interferon, like most conventional antineoplastic drugs, is based on exactly the opposite calculus: it is known to have severe toxic side effects, but its clinical efficacy in prolonging remission has been validated to some extent-at least for those patients who are able to tolerate the adverse side effects.
Another calculus that differs in the conventional and integrative approaches is mentioned specifically by Uzick: the strategy of using several changes together that could have a cumulative effect, although each one alone may not have a significant effect on survival or other important outcomes. This is an approach that I have followed for more than 2 decades, and, with few exceptions, I find it to be generally accurate. This is not to suggest that nonspecific, generic approaches to illness cannot help patients. But when multiple interventions are individualized as a cumulative strategy for the patient, I believe improved outcomes can be seen.
Uzick follows the typical naturopathic approach of investigating possible leads for treatment approaches by following up the epidemiological literature. Thus, he proposes lifestyle interventions based on variables that have established relationships to melanoma occurrence, such as alcohol use, exercise, and toxic metals. The association of melanoma with obesity and low exercise levels is quite interesting. In light of the recent controversy about the relationship of overweight and obesity to survival, 2 it is useful to remember that this discussion has focused on overweight and overall mortality from all causes. 3 No one has yet questioned the relationship between obesity and cancer highlighted in the references cited by Uzick as well as other important recent references in this area. 4 I am not aware of any literature specifying cytotoxic effects or evidence of slowing tumor progression by chelation of arsenic or nickel. Interestingly, though, there have been some in vitro and in vivo observations of antitumor effects of iron-chelating drugs. 5 Iron may play a vital physiological role in the growth and proliferation of cancer cells, 6 so a role for iron-chelating drugs is of potential interest.
Uzick's designation of the multicenter, retrolective cohort study by Augustin et al 7 as a "controlled clinical
